Genome wide analysis of DNA methylation and nucleosome positioning

Por Jones, Peter A
Publicado em 2013

At the tipping point for epigenetic therapies in cancer

Por Jones, Peter A.
Publicado em 2014

Comprehensive analysis of CpG islands in human chromosomes 21 and 22

Por Takai, Daiya, Jones, Peter A.
Publicado em 2002

Rethinking how DNA Methylation Patterns are Maintained

Por Jones, Peter A., Liang, Gangning
Publicado em 2009

Altered DNA methylation and genome instability: A new pathway to cancer?

Por Jones, Peter A., Gonzalgo, Mark L.
Publicado em 1997

The Human ARF Cell Cycle Regulatory Gene Promoter Is a CpG Island Which Can Be Silenced by DNA Methylation and Down-Regulated by Wild-Type p53

Por Robertson, Keith D., Jones, Peter A.
Publicado em 1998

Chromatin, Cancer and Drug Therapies

Por Cortez, Connie C., Jones, Peter A.
Publicado em 2008

MicroRNAs: critical mediators of differentiation, development and disease

Por Friedman, Jeffrey M., Jones, Peter A.
Publicado em 2009

A decade of exploring the cancer epigenome — biological and translational implications

Por Baylin, Stephen B., Jones, Peter A.
Publicado em 2011

Cancer Genetics and Epigenetics: Two Sides of the Same Coin?

Por You, Jueng Soo, Jones, Peter A.
Publicado em 2012

The Epigenomics of Cancer

Por Jones, Peter A., Baylin, Stephen B.
Publicado em 2007

Epigenetic Determinants of Cancer

Por Baylin, Stephen B., Jones, Peter A.
Publicado no Cold Spring Harb Perspect Biol (2016)

Establishment of conditional vectors for hairpin siRNA knockdowns

Por Matsukura, Shiro, Jones, Peter A., Takai, Daiya
Publicado em 2003

Medical treatment at the Glastonbury Festival: Safeguard the “National” in National Health Service

Por Sandison, A J P, Jones, Peter A
Publicado em 1993

Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation

Por Nguyen, Carvell T., Gonzales, Felicidad A., Jones, Peter A.
Publicado em 2001

Evidence for the binding of the carcinogen 3-methylcholanthrene to both the purine and the pyrimidine bases of hamster fibroblast deoxyribonucleic acid (Short Communication)

Por Jones, Peter A., Gevers, Wieland, Hawtrey, Arthur O.
Publicado em 1973

Epigenetics in cancer

Por Sharma, Shikhar, Kelly, Theresa K., Jones, Peter A.
Publicado em 2010

The tumor suppressor microRNA-101 becomes an epigenetic player by targeting the Polycomb group protein EZH2 in cancer

Por Friedman, Jeffrey M., Liang, Gangning, Jones, Peter A.
Publicado em 2009

Targeting DNA Methylation for Epigenetic Therapy

Por Yang, Xiaojing, Lay, Fides, Han, Han, Jones, Peter A.
Publicado em 2010

DNA Methylation and Cellular Reprogramming

Por De Carvalho, Daniel D, You, Jueng Soo, Jones, Peter A
Publicado em 2010